(Q40774723)

23 September 2017

title

Optimization of retroviral vector generation for clinical application (English)

1 reference

23 September 2017

Schilz AJ

1

1 reference

23 September 2017

Kühlcke K

series ordinal

2

1 reference

23 September 2017

Fauser AA

series ordinal

3

1 reference

23 September 2017

Eckert HG

series ordinal

4

1 reference

23 September 2017

publication date

1 September 2001

1 reference

23 September 2017

published in

Journal of Gene Medicine

1 reference

23 September 2017

volume

3

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

427-436

1 reference

Gene therapy -- promises, problems and prospects

23 September 2017

cites work

1 reference

Human somatic gene therapy: progress and problems

21 January 2018

1 reference

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

21 January 2018

1 reference

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

21 January 2018

1 reference

Gene therapy turns the corner.

21 January 2018

1 reference

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer

21 January 2018

1 reference

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

21 January 2018

1 reference

Improved methods of retroviral vector transduction and production for gene therapy

21 January 2018

1 reference

Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein

21 January 2018

1 reference

Increased viral titer through concentration of viral harvests from retroviral packaging lines

21 January 2018

1 reference

Combined ultrafiltration-transduction in a hollow-fiber bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II.

21 January 2018

1 reference

Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1).

21 January 2018

1 reference

MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions.

21 January 2018

1 reference

Retroviral preparations derived from PA317 packaging cells contain inhibitors that copurify with viral particles and are devoid of viral vector RNA.

21 January 2018

1 reference

Optimized conditions for the production of recombinant amphotropic retroviral vector preparations

21 January 2018

1 reference

High-efficiency retroviral transduction of mammalian cells on positively charged surfaces.

21 January 2018

1 reference

Human gene marker/therapy clinical protocols

21 January 2018

1 reference

Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JGM.204

1 reference

23 September 2017

1 reference